Almirall, S.A. (BME:ALM)
Spain · Delayed Price · Currency is EUR 12.86
-0.34 (-2.58%)
At close: Feb 26, 2026
Almirall Market Cap
Almirall has a market cap or net worth of €2.76 billion as of February 26, 2026. Its market cap has increased by 42.35% in one year.
Market Cap
2.76B
Enterprise Value
2.77B
Revenue
1.11B
Ranking
n/a
PE Ratio
59.63
Stock Price
€12.86
Market Cap Chart
Since June 20, 2007, Almirall's market cap has increased from 2.37B to 2.76B, an increase of 16.47%. That is a compound annual growth rate of 0.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 2.76B | 0.16% |
| Dec 31, 2025 | 2.76B | 56.88% |
| Dec 31, 2024 | 1.76B | -0.35% |
| Dec 29, 2023 | 1.76B | 7.51% |
| Dec 30, 2022 | 1.64B | -19.23% |
| Dec 30, 2021 | 2.03B | 4.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.66B |
| Laboratorios Farmaceuticos Rovi | 3.99B |
| Faes Farma | 1.55B |
| Pharma Mar | 1.35B |
| Clínica Baviera | 839.03M |
| Oryzon Genomics | 246.02M |
| Atrys Health | 235.21M |
| Prim, S.A. | 217.80M |